Posted: 05/02/2025 07:54 am
OrthoPediatrics Corp., a global leader in the pediatric orthopedic sector, demonstrated a strategic approach in aligning executive compensation with its growth trajectory and business initiatives. The compensation dynamics within the company provide insights into its operational priorities as well as its efforts to retain key talent in a competitive industry.
In 2024, Fred L. Hite, the Chief Operating Officer and Chief Financial Officer, received a total compensation package of approximately $2.58 million. This package comprised a base salary of $501,000, while the stock awards accounted for $1.7 million, indicating a robust emphasis on equity-based incentives to align the leadership's interests with shareholder value. Interestingly, no bonuses or option awards were recorded for Hite that year, yet he received significant compensation via the company's incentive plan, totaling $367,082. Additionally, he received $13,800 under 'all other compensation', reflecting diverse performance benefits.^1
Comparatively, in 2023, Gregory A. Odle, then President of Scoliosis, earned a total compensation of $1.35 million. His salary stood at $353,100 with stock awards constituting $813,909 of the total package. Incentive compensation amounted to $171,695, while 'all other compensation' was slightly lower at $13,200. The upward trend from 2022, where Odle's total compensation was $1.05 million, reflects OrthoPediatrics' strategic focus on retaining leaders integral to specific product categories, dovetailing with their business expansion endeavors.^2^3
In earlier years, such as in 2021, the focus was on a different set of leadership roles, as evidenced by Joseph W. Hauser's compensation. Hauser, serving as Senior Vice President & General Manager of Trauma and Deformity Correction, earned $742,296. His stock awards were notably less than recent figures, suggesting evolving compensation strategies in alignment with company performance and growth metrics.^4
In a peculiar case, Mark C. Throdahl, CEO in 2018, was reported with a salary figure appearing to be an anomaly at $2.15 billion, which due to an evident reporting error, overshadowed the rest of his compensation details. This incident underscores the importance of accurate reporting and its implications.^5
Amidst these compensation configurations, OrthoPediatrics has made significant strides in its operational front. In 2025, the company achieved record revenue, launching products like the VerteGlide™ System, showing a positive correlation between executive incentives and company performance.^6^7 The firm's market price, as of recent reports, stands at $20.93, with the market capitalization touching $519 million, indicating a vibrant period for OrthoPediatrics despite prevailing challenges in the broader medical industry.^8
The synergy between OrthoPediatrics' compensation strategies and its market initiatives paints a promising picture for prospective investors and stakeholders, fostering a work environment that recently earned it the distinction as one of the "Best Places to Work in Indiana."^9 This alignment not only enhances corporate governance but also progresses toward their mission to advance pediatric orthopedics globally.
---
:
1. [Fred L. Hite's 2024 Compensation](https://www.sec.gov/Archives/edgar/data/1425450/000142545025000033/0001425450-25-000033-index.htm)
2. [Gregory A. Odle's 2023 Compensation](https://www.sec.gov/Archives/edgar/data/1425450/000142545024000027/0001425450-24-000027-index.htm)
3. [Gregory A. Odle's 2022 Compensation](https://www.sec.gov/Archives/edgar/data/1425450/000142545023000061/0001425450-23-000061-index.htm)
4. [Joseph W. Hauser's 2021 Compensation](https://www.sec.gov/Archives/edgar/data/1425450/000142545022000045/0001425450-22-000045-index.htm)
5. [Mark C. Throdahl's 2018 Compensation](https://www.sec.gov/Archives/edgar/data/1425450/000142545021000060/0001425450-21-000060-index.htm)
6. [VerteGlide™ System Launch](https://www.globenewswire.com/news-release/2025/04/08/3057581/0/en/OrthoPediatrics-Corp-Expands-Scoliosis-Portfolio-with-Launch-of-VerteGlide-System.html)
7. [Full Year Financial Results Announcement](https://www.globenewswire.com/news-release/2025/03/17/3044080/0/en/OrthoPediatrics-Corp-Joins-Crossroads-Pediatric-Device-Consortium-to-Advance-Pediatric-Medical-Device-Innovation.html)
8. [OrthoPediatrics Corp. Stock Price Data](https://www.globenewswire.com/news-release/2025/02/19/3028748/0/en/OrthoPediatrics-Corp-to-Report-Fourth-Quarter-and-Full-Year-2024-Financial-Results-on-March-4-2025.html)
9. [Best Places to Work Recognition](https://www.globenewswire.com/news-release/2025/03/24/3048291/0/en/OrthoPediatrics-Corp-Named-One-the-2025-Best-Places-to-Work-in-Indiana.html)
